Clinical Trial Update: Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 clinical study evaluating the safety and efficacy of BiTE-EV in relapsed/refractory acute lymphoblastic leukemia, currently recruiting at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• BiTE-EV

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: Leukemia | EARLY_Phase 1 | Status: RECRUITING